Showing 1881-1890 of 3240 results for "".
BUSINESS ADVISOR: The Just-in-Time Model: Smart Inventory Management in Tough Economic Times
https://practicaldermatology.com/topics/general-topics/the-just-in-time-model-smart-inventory-management-in-tough-economic-times/21963/Meeting inventory challenges can help control costs and ensure consistent cash flow during economic difficulties.Systemic Treatment for Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/systemic-treatment-for-skin-cancers/19662/Anisha B. Patel, MD discusses the latest advances in systemic treatment for melanoma with host Joshua Zeichner, MD. She reviews how treatments work, the most common cutaneous reactions patients experience, and the dermatologist's role in managing those reactions and reassuring patients that these reSuperficial Radiation for Keloids: SRT-100 in Practice
https://practicaldermatology.com/topics/skin-cancer-photoprotection/superficial-radiation-for-keloids-srt-100-in-practice/19040/Keloids are common. Certain patients, especially patients of color, are more prone to the development of keloids in certain locations, especially areas such as the chest, back, and other areas. Most studies that show that keloids can occur in up to 90 percent of cases when they're excised. The use oBryhali, Xepi Launches; Epionce's New Facility
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-bryhali-xepi-launches-epionce-s-new-facility/18213/Bryhali (halobetasol propionate) 0.01% Lotion from Ortho Dermatologics is now available for the topical treatment of plaque psoriasis in adults. Lawrence J. Green, MD a lead investigator on the Phase 3 studies speaks to DermWireTV. Botanical-based skincare company Epionce has a new 18,500 square fooHitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
https://practicaldermatology.com/programs/cme/hitting-the-target-in-atopic-dermatitis-interdisciplinary-team-training-for-leveraging-il-13-inhibitors-to-address-the-burden-of-disease/54437/On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.2022 in Review
https://practicaldermatology.com/topics/other-dermatology/2022-in-review/23833/The past year brought many new approvals and advances to dermatology for improved patient care.Preparing for the Future of Teledermatology
https://practicaldermatology.com/issues/supplements/preparing-for-the-future-of-teledermatology/23475/Telehealth served as an important stopgap for medical providers and their patients in the context of the COVID-19 pandemic, but will it persist? And if so, how can you derive the most benefit?Top 10 Considerations in Supplements for Hair
https://practicaldermatology.com/issues/september-2026/top-10-considerations-in-supplements-for-hair/70061/As dietary supplements and nutraceuticals are increasingly integrated into hair health management, understanding their appropriate use is essential.A Rational Criteria: When Not to Treat Warts
https://practicaldermatology.com/topics/infections-infectious-disease/a-rational-criteria-when-not-to-treat-warts/23813/How to decide which warts to let resolve on their own.An Update on At-Home UVB Phototherapy
https://practicaldermatology.com/topics/general-topics/an-update-on-at-home-uvb-phototherapy/21786/At-home options increase accessibility to phototherapy, which is effective and generally safe for psoriasis management.